TScan Therapeutics
TCRX
TCRX
54 hedge funds and large institutions have $187M invested in TScan Therapeutics in 2023 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 13 increasing their positions, 4 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
8.16% more ownership
Funds ownership: 65.66% → 73.82% (+8.2%)
Holders
54
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$1.22M | |
| 2 | +$1.17M | |
| 3 | +$645K | |
| 4 |
Millennium Management
New York
|
+$578K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$507K |
Top Sellers
| 1 | -$583K | |
| 2 | -$68.2K | |
| 3 | -$50.8K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$2.13K |